Purchase Order 75F40124P00465
Award Date 9/11/24
Potential Completion Date 9/29/25
Potential Value $196K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carmel-By-The-Sea, CA 93921, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Active Health Science LLC, a veteran-owned small business, to provide support for the Vaccine Adverse Event Reporting System (VAERS) and safety monitoring for COVID-19 vaccines. The contract, valued at $245,050.00, runs through September 29, 2023 and does not have a set-aside designation. Active Health Science LLC has received multiple previous contract awards from the Department...
- This is a firm fixed-price purchase order contract awarded to Active Health Science LLC, a veteran-owned small business, by the Food and Drug Administration (FDA). The contract is for $187,200.00 and runs from September 3, 2025 to September 29, 2026. It is a total small business set-aside award. The contract is for the Vaccine Adverse Event Reporting System (VAERS) and safety monitoring support for COVID-19 vaccines. Active Health Science LLC will provide medical and scientific support...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
- The Department of Health and Human Services Food and Drug Administration awarded a $539,809 purchase order contract to Iqvia Government Solutions Inc. of Mosby, Virginia to provide COVID-19 real-world evidence/data agile analytics and specialized data sets. Under this contract, Iqvia will leverage its expertise in data analytics to support the FDA's efforts to monitor the real-world impact of COVID-19 through analysis of specialized data sets. The one-year contract commenced on September 29,...
- This is a $622,019,089.47 cost-plus-award-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Constella Group LLC, a subcontractor. The contract, awarded on September 1, 2004, is for the Vaccine Adverse Event Reporting System (VAERS) and has an ultimate completion date of October 7, 2011. The contract is a definitive contract and does not have a set-aside designation. The award is under a larger CDC program, though details on the specific program are not provided.
- This is a $6,977,921.68 firm fixed-price delivery order awarded to General Dynamics Information Technology, Inc. (GDIT) under the Alliant II Government-Wide Acquisition Contract (GWAC) to provide enhancements to the Vaccine Adverse Event Reporting System (VAERS) for the Centers for Disease Control and Prevention (CDC). The period of performance extends to May 14, 2025. GDIT will be the prime contractor, with several small business subcontractors including Novacis Digital, LLC, Exafluence Inc.,...
- This is a Firm Fixed Price Delivery Order awarded by the Food and Drug Administration (FDA) to Mcneal Professional Services, Inc., a self-certified small disadvantaged, woman-owned small business. The $583,507.20 contract is to provide a SCIENTIST I to support the FDA's Center for Biologics Evaluation and Research (CBER) and Office of Vaccines Research and Review (OVRR) in performing mission-critical research to support vaccine safety and efficacy. The contract has a period of performance...
- This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023. The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from...
- This federal contract award, valued at $145,664.28, was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to Fisher Scientific Company L.L.C., Fisher Healthcare Division, doing business as Fisher Healthcare. The contract does not have a set-aside designation. Under this firm fixed price purchase order, Fisher Healthcare will provide a range of medical equipment, testing reagents, laboratory supplies, and inventory services to...
- The United States Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $428,021.98 delivery order contract to Versar Inc. under the Multiple Award Schedule (MAS) master contract vehicle. The contract provides Peer Review and Scientific Assessment Support services to HHS FDA from the prime contractor's place of performance in Silver Spring, Maryland. The period of performance spans from September 26, 2022 through March 31, 2024 and utilizes labor hour pricing.